<DOC>
	<DOCNO>NCT00691834</DOCNO>
	<brief_summary>The purpose study test bone marrow mononuclear cell patient recent heart attack high risk experience heart failure . This study drug make cell . Studies similar one suggest use cell-based transfer heart attack improve recuperation heart . The purpose study ass whether cell transfer improve heal heart heart attack .</brief_summary>
	<brief_title>Safety Efficacy Cell-based Therapy Patients With Recent Large Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Be least 18 year age 80 year age . Acute STsegment elevation MI Symptoms suggestive acute MI ≥ 2mm STsegment elevation 2 precordial lead ≥ 1mm limb lead new left bundle branch block Time symptom onset enrollment &lt; 120 hour Left ventricular dysfunction contrast ventriculography echocardiography EF 25 % low 40 % Focal wall motion akinesis dyskinesis Clearly identifiable infarct artery Patent infarct artery ( TIMI flow grade 2 3 ) ≥ 2 mm diameter follow successful stent placement Planned treatment bypass surgery prior CABG Multivessel PCI Prior myocardial infarction history presence pathologic Qwaves Active cardiogenic shock : mechanical ventilation , IABP , vasopressors/inotropes Successful reperfusion &lt; 3 hr symptom onset Prior MI significant chronic heart failure Pacemaker/defibrillator Contraindication MRI ( metallic foreign body , claustrophobia , inability lie flat ) Significant hepatic dysfunction renal insufficiency ( estimate creatinine clearance &lt; 25 and/or serum Cr &gt; 2.5 mg/dl ) Baseline hematocrit &lt; 30 Pregnancy , lactation/parturition within past 30 day Active plan treatment chemotherapy Anticipated difficulty 90day followup Evidence serious , active infection opinion investigator include , limited subject HIV , hepatitis B C positive Any known severe hematological disease , malignancy , systemic life threaten disorder would incompatible trial Previous enrollment trial Participation investigational drug device study within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Magnetic resonance Imaging</keyword>
</DOC>